Resmed 

$230.84
495
-$1.57-0.68% Friday 20:00

Statistics

Day High
235.8
Day Low
230.22
52W High
293.81
52W Low
199.92
Volume
1,002,505
Avg. Volume
1,074,835
Mkt Cap
33.63B
P/E Ratio
25.24
Dividend Yield
1.04%
Dividend
2.4

Upcoming

Dividends

1.04%Dividend Yield
Mar 26
$0.6
Dec 25
$0.6
Sep 25
$0.6
Jun 25
$0.53
Mar 25
$0.53
10Y Growth
6.66%
5Y Growth
8.18%
3Y Growth
9.26%
1Y Growth
6.19%

Earnings

23AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
2.05
2.31
2.56
2.82
Expected EPS
2.818675
Actual EPS
N/A

Financials

27.22%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
10.29BRevenue
2.8BNet Income

Analyst Ratings

$294.11Average Price Target
The highest estimate is 345.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
56%
Hold
44%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RMD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Philips Respironics, a subsidiary of Philips, competes directly with ResMed in the sleep and respiratory care market, offering CPAP machines, ventilators, and other respiratory products.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare is a leading manufacturer of respiratory care products, including CPAP devices and humidifiers, directly competing with ResMed's product offerings.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers a range of medical devices that compete with ResMed, particularly in the ventilation and monitoring systems for respiratory conditions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes with ResMed in the medical device sector, particularly in areas of sleep and respiratory care through its various healthcare solutions.
GE Aerospace
GE
Mkt Cap325.88B
General Electric, through its healthcare division, provides medical devices and technologies that compete with ResMed's offerings, including respiratory care and sleep solutions.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew, while primarily known for orthopedics, competes with ResMed through its products in the medical equipment sector, including devices for wound management that can intersect with care for sleep-related conditions.
Stryker
SYK
Mkt Cap136.19B
Stryker competes with ResMed in the broader medical technology and devices market, offering products that can be used in surgical and critical care settings which may overlap with ResMed's market.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet, primarily focused on musculoskeletal healthcare, competes with ResMed in the medical device market, offering products that can indirectly affect sleep and respiratory health.
Hologic
HOLX
Mkt Cap16.45B
Hologic offers medical devices and technology that compete with ResMed, particularly in the diagnostics and treatment of sleep disorders through its imaging and digital health solutions.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, known for its robotic surgical systems, competes with ResMed in the broader healthcare technology space, offering innovative solutions that can impact the treatment of conditions related to sleep and respiratory care.

About

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Michael J. Farrell BE, MBA, SM
Employees
9980
Country
US
ISIN
US7611521078

Listings

0 Comments

Share your thoughts

FAQ

What is Resmed stock price today?
The current price of RMD is $230.84 USD — it has decreased by -0.68% in the past 24 hours. Watch Resmed stock price performance more closely on the chart.
What is Resmed stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Resmed stocks are traded under the ticker RMD.
Is Resmed stock price growing?
RMD stock has fallen by -8.71% compared to the previous week, the month change is a -8.6% fall, over the last year Resmed has showed a +3.02% increase.
What is Resmed market cap?
Today Resmed has the market capitalization of 33.63B
When is the next Resmed earnings date?
Resmed is going to release the next earnings report on April 23, 2026.
What were Resmed earnings last quarter?
RMD earnings for the last quarter are 2.81 USD per share, whereas the estimation was 2.74 USD resulting in a +2.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Resmed revenue for the last year?
Resmed revenue for the last year amounts to 10.29B USD.
What is Resmed net income for the last year?
RMD net income for the last year is 2.8B USD.
Does Resmed pay dividends?
Yes, RMD dividends are paid quarterly. The last dividend per share was 0.6 USD. As of today, Dividend Yield (FWD)% is 1.04%.
How many employees does Resmed have?
As of March 15, 2026, the company has 9,980 employees.
In which sector is Resmed located?
Resmed operates in the Health Care sector.
When did Resmed complete a stock split?
The last stock split for Resmed was on August 31, 2010 with a ratio of 2:1.
Where is Resmed headquartered?
Resmed is headquartered in San Diego, US.